Point72 Hong Kong LTD Albireo Pharma, Inc. Transaction History

Point72 Hong Kong LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$16.32 - $26.37 $53,921 - $87,126	3,304 New	3,304 $64,000
Q2 2022 Aug 15, 2022	SELL	$18.54 - $37.29 $12,273 - $24,685	-662 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$23.94 - $33.74 $454 - $641	-19 Reduced 2.79%	662 $20,000
Q4 2021 Feb 14, 2022	BUY	$21.19 - $31.29 $14,430 - $21,308	681 New	681 $16,000
Q4 2020 Feb 16, 2021	SELL	$31.56 - $42.16 $12,024 - $16,062	-381 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$23.19 - $41.61 $8,835 - $15,853	381 New	381 $13,000
Q4 2019 Feb 14, 2020	SELL	$16.92 - $28.96 $947 - $1,621	-56 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$20.0 - $31.88 $1,120 - $1,785	56 New	56 $1,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.